BRPI0921917B8 - formulação farmacêutica. - Google Patents
formulação farmacêutica.Info
- Publication number
- BRPI0921917B8 BRPI0921917B8 BRPI0921917A BRPI0921917A BRPI0921917B8 BR PI0921917 B8 BRPI0921917 B8 BR PI0921917B8 BR PI0921917 A BRPI0921917 A BR PI0921917A BR PI0921917 A BRPI0921917 A BR PI0921917A BR PI0921917 B8 BRPI0921917 B8 BR PI0921917B8
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical formulation
- fatty acid
- acid group
- carbon atoms
- fat emulsion
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 208000028399 Critical Illness Diseases 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 125000005313 fatty acid group Chemical group 0.000 abstract 2
- 239000002960 lipid emulsion Substances 0.000 abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 208000021642 Muscular disease Diseases 0.000 abstract 1
- 201000009623 Myopathy Diseases 0.000 abstract 1
- 206010036105 Polyneuropathy Diseases 0.000 abstract 1
- 230000007824 polyneuropathy Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Dispersion Chemistry (AREA)
- Neurology (AREA)
- Polymers & Plastics (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Neurosurgery (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
formulação farmacêutica, emulsão de gordura e usos a presente invenção refere-se a uma formulação farmacêutica para o tratamento e profilaxia de polineuropatia do paciente crítica (cip) e miopatia do paciente crítico (cim). ainvenção ainda refere-se a uma emulsão de gordura isotônica compreendendo pelo menos um triglicerídeo que compreende pelo menos um grupo de ácidos graxos com um número ímpar de átomos de carbono, no qual o grupo de ácido graxo é uma cadeia de carbono tendo 5 a 15 átomos de carbono.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102008057867.3 | 2008-11-18 | ||
DE102008057867A DE102008057867A1 (de) | 2008-11-18 | 2008-11-18 | Fettemulsion zur künstlichen Ernährung von schwerkranken Intensivpatienten |
PCT/EP2009/064839 WO2010057804A1 (de) | 2008-11-18 | 2009-11-09 | Fettemulsion zur künstlichen ernährung von schwerkranken intensivpatienten |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0921917A2 BRPI0921917A2 (pt) | 2015-12-29 |
BRPI0921917B1 BRPI0921917B1 (pt) | 2020-08-25 |
BRPI0921917B8 true BRPI0921917B8 (pt) | 2021-05-25 |
Family
ID=41581163
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0921917A BRPI0921917B8 (pt) | 2008-11-18 | 2009-11-09 | formulação farmacêutica. |
Country Status (12)
Country | Link |
---|---|
US (2) | US20110207819A1 (pt) |
EP (1) | EP2355813B1 (pt) |
JP (1) | JP2012509292A (pt) |
KR (1) | KR20110084513A (pt) |
CN (1) | CN102215839B (pt) |
BR (1) | BRPI0921917B8 (pt) |
CA (1) | CA2739390C (pt) |
DE (1) | DE102008057867A1 (pt) |
ES (1) | ES2561207T3 (pt) |
MX (1) | MX338223B (pt) |
RU (1) | RU2528108C2 (pt) |
WO (1) | WO2010057804A1 (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102009013914B4 (de) * | 2009-03-19 | 2011-05-05 | Bruker Daltonik Gmbh | Kalibriersubstanzen für Atmosphärendruck-Ionenquellen |
CN103338761A (zh) * | 2011-01-31 | 2013-10-02 | 日本脏器制药株式会社 | 抗癌剂所引起的周围神经病的预防或治疗剂 |
US8183227B1 (en) | 2011-07-07 | 2012-05-22 | Chemo S. A. France | Compositions, kits and methods for nutrition supplementation |
US8168611B1 (en) | 2011-09-29 | 2012-05-01 | Chemo S.A. France | Compositions, kits and methods for nutrition supplementation |
CN106900888B (zh) * | 2015-12-23 | 2021-12-24 | 丰益(上海)生物技术研发中心有限公司 | 含有奇数碳脂肪酸结构脂的油脂组合物及其应用 |
US11406616B2 (en) * | 2016-06-08 | 2022-08-09 | Sunregen Healthcare Ag | Lipids with odd number of carbon atoms and their use as pharmaceutical composition or nutritional supplement |
CN109602704A (zh) * | 2019-01-23 | 2019-04-12 | 广东嘉博制药有限公司 | 丁酸氯维地平脂肪乳注射液及其制备工艺 |
CN110326789A (zh) * | 2019-06-11 | 2019-10-15 | 上海互众药业有限公司 | 一种脂肪乳食品补充液及其制备方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2515174A1 (fr) | 1981-10-23 | 1983-04-29 | Roussel Uclaf | Nouveaux triglycerides, procede de preparation et d'applications en dietetique et en therapeutique |
US4526902A (en) | 1983-10-24 | 1985-07-02 | Century Laboratories, Inc. | Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions |
DE3721137A1 (de) | 1987-06-26 | 1989-01-05 | Dietl Hans | Fettemulsion zur intravenoesen anwendung |
DE3722540A1 (de) | 1987-07-08 | 1989-01-19 | Fresenius Ag | Fettemulsion, verfahren zu ihrer herstellung und ihre verwendung |
DE3734147C2 (de) * | 1987-10-09 | 1998-10-29 | Braun Melsungen Ag | Isotone omega-3-fettsäurenhaltige Fettemulsion und ihre Verwendung |
AU682894B2 (en) * | 1993-10-28 | 1997-10-23 | Institut National De La Recherche Agronomique | Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction, in animals and man |
RU2155612C2 (ru) * | 1997-01-30 | 2000-09-10 | Скрипченко Наталия Викторовна | Способ лечения острых инфекционных заболеваний периферической нервной системы |
US6740679B1 (en) | 1999-02-05 | 2004-05-25 | Baylor University Medical Center | Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid |
ATE303079T1 (de) * | 1999-02-05 | 2005-09-15 | Baylor Res Inst | Nahrungsergänzung oder pharmazeutische zusammensetzung enthaltend triglyceride bestehend aus fettsäuren mit 7 kohlenstoffatomen |
US20030162833A1 (en) * | 2001-08-01 | 2003-08-28 | Roe Charles R. | Fatty acid treatment for cardiac patients |
DK1434597T3 (da) * | 2001-10-11 | 2012-02-27 | Merck Serono Sa | Anvendelse af gp130-aktivatorer ved diabetisk neuropati |
EP1628622A4 (en) * | 2003-05-20 | 2008-12-17 | Baylor Res Inst | FIVE AND FIFTH CARBON FATTY ACIDS FOR THE TREATMENT OF METABOLISM DISORDERS AND AS FOOD SUPPLEMENTS |
CA2573054C (en) * | 2004-07-02 | 2012-10-09 | Baylor Research Institute | Glycogen or polysaccharide storage disease treatment method |
ATE358468T1 (de) * | 2005-02-16 | 2007-04-15 | Straetmans Chemische Produktio | Kosmetische und dermatologische lichtschutzformulierungen mit einem gehalt an chemischen uv-filtern und triheptanonin |
WO2008039855A2 (en) | 2006-09-26 | 2008-04-03 | Baylor Research Institute | Nutrient sensor |
-
2008
- 2008-11-18 DE DE102008057867A patent/DE102008057867A1/de not_active Withdrawn
-
2009
- 2009-11-09 CN CN200980145702.6A patent/CN102215839B/zh not_active Ceased
- 2009-11-09 EP EP09760502.6A patent/EP2355813B1/de active Active
- 2009-11-09 CA CA2739390A patent/CA2739390C/en active Active
- 2009-11-09 JP JP2011536823A patent/JP2012509292A/ja active Pending
- 2009-11-09 RU RU2011124887/15A patent/RU2528108C2/ru active
- 2009-11-09 US US13/126,245 patent/US20110207819A1/en not_active Abandoned
- 2009-11-09 KR KR1020117010418A patent/KR20110084513A/ko not_active Application Discontinuation
- 2009-11-09 ES ES09760502.6T patent/ES2561207T3/es active Active
- 2009-11-09 MX MX2011005201A patent/MX338223B/es active IP Right Grant
- 2009-11-09 WO PCT/EP2009/064839 patent/WO2010057804A1/de active Application Filing
- 2009-11-09 BR BRPI0921917A patent/BRPI0921917B8/pt active IP Right Grant
-
2015
- 2015-11-03 US US14/930,723 patent/US20160051506A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
BRPI0921917B1 (pt) | 2020-08-25 |
BRPI0921917A2 (pt) | 2015-12-29 |
DE102008057867A1 (de) | 2010-05-20 |
ES2561207T3 (es) | 2016-02-25 |
EP2355813B1 (de) | 2015-11-04 |
JP2012509292A (ja) | 2012-04-19 |
MX2011005201A (es) | 2011-06-01 |
CA2739390A1 (en) | 2010-05-27 |
CN102215839B (zh) | 2016-08-24 |
KR20110084513A (ko) | 2011-07-25 |
RU2011124887A (ru) | 2012-12-27 |
WO2010057804A1 (de) | 2010-05-27 |
EP2355813A1 (de) | 2011-08-17 |
US20160051506A1 (en) | 2016-02-25 |
US20110207819A1 (en) | 2011-08-25 |
MX338223B (es) | 2016-04-08 |
CN102215839A (zh) | 2011-10-12 |
RU2528108C2 (ru) | 2014-09-10 |
CA2739390C (en) | 2016-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0921917B8 (pt) | formulação farmacêutica. | |
CU20140151A7 (es) | Composición farmacéutica útil en la prevención de un evento cardiovascular mayor | |
BR112015026446A2 (pt) | composição cosmética contendo uma fase oleosa compreendendo um elastômero de silicone em gotículas aquosas dispersas e um surfactante particular | |
BR112018076693A2 (pt) | análogos de urocortina-2 modificados por ácido graxo, para o tratamento de diabetes e doença renal crônica | |
CL2011002268A1 (es) | Uso de compuestos derivados de acidos grasos poliinsaturados para el tratamiento de enfermedades neurodegenerativas y neurologicas; y composicion farmaceutica o nutraceutica. | |
CO6300949A2 (es) | Regimen de dosificacion asociado con esteres de paliperidona inyectables de accion prolongada | |
BR112012014967A2 (pt) | composição clara ou translúcia | |
BR112015017572A2 (pt) | emulsão aquosa, uso da emulsão, método de fabricação da emulsão, método para operar um tomógrafo e método para detectar um composto semifluorado | |
BR122020000059B8 (pt) | composição que compreende uma matriz biocompatível e um fator de crescimento derivado de plaqueta e kit | |
BR112013022480A2 (pt) | processo para determinação de propriedade de combustível | |
BR112014030344A2 (pt) | lembretes de ciência de localização | |
BR112014019090A8 (pt) | Método e aparelho | |
ES2629407T3 (es) | Soluciones acuosas que contienen un agente complejante en alta concentración | |
BR112017012562A2 (pt) | lubrificante para alta temperatura para a indústria alimentícia | |
BR112015013349A2 (pt) | trieptanoína para o tratamento de deficiência de transportador de glicose 1 | |
BR112018000242A2 (pt) | composições nutricionais contendo fosfatidiletanolamina, esfingomielina e ácido doco-saexaenóico | |
BR112017006416A2 (pt) | composição nutricional para meio gastrointestinal para proporcionar perfil aperfeiçoado de microbioma e metabólico | |
BR112017018431A2 (pt) | película auto-sustentável a base de um éster de ácido hialurônico e método de preparação da película | |
BR112018077500A2 (pt) | alimento animal que compreende uma composição de ácido graxo poli-insaturado ômega-3 | |
BR112013014647A2 (pt) | emulsão de água em óleo, processo para a preparação de uma emulsão de água em óleo comestível e uso de uma gordura de triglicerídeo de hhh | |
BR112012017202A2 (pt) | composição transparente ou translúcida | |
BR112017010968A2 (pt) | formulação aquosa, processo para preparação de uma solução aquosa, e, uso de soluções aquosas. | |
BR112015023849A2 (pt) | formulação farmacêutica que compreende fosfatidilcolina para o tratamento de colite ulcerativa | |
BR112012030643A2 (pt) | líquido da casca da castanha de caju tendo estabilidade melhorada | |
BR112017012348A2 (pt) | tensoativo de açúcar e uso do mesmo em composições agroquímicas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B15K | Others concerning applications: alteration of classification |
Ipc: A61K 31/225 (2006.01), A23L 33/12 (2016.01), A61K |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 25/08/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 09/11/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |